AKT1 and diabetes mellitus: The nanoparticle-encapsulated curcumin treatment decreased the up-regulated P2Y12 expression levels in the DRG, reduced the up-regulation of IL-1β and Cx43, and decreased p-Akt levels in the DRG of DM rats.